NO20031308L - Effektiv fremgangsmåte for fremstilling av en faktor XA- inhibitor - Google Patents

Effektiv fremgangsmåte for fremstilling av en faktor XA- inhibitor

Info

Publication number
NO20031308L
NO20031308L NO20031308A NO20031308A NO20031308L NO 20031308 L NO20031308 L NO 20031308L NO 20031308 A NO20031308 A NO 20031308A NO 20031308 A NO20031308 A NO 20031308A NO 20031308 L NO20031308 L NO 20031308L
Authority
NO
Norway
Prior art keywords
inhibitor
preparing
factor
effective method
effective
Prior art date
Application number
NO20031308A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031308D0 (no
Inventor
Luigi Anzalone
Fuqiang Jin
David J Meloni
Jung-Hui Sun
Christopher A Teleha
Jia Cheng Zhou
Thomas E Smyser
Hui-Yin Li
Original Assignee
Bristol Myers Squibb Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Pharma Co filed Critical Bristol Myers Squibb Pharma Co
Publication of NO20031308D0 publication Critical patent/NO20031308D0/no
Publication of NO20031308L publication Critical patent/NO20031308L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20031308A 2000-09-22 2003-03-21 Effektiv fremgangsmåte for fremstilling av en faktor XA- inhibitor NO20031308L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23462200P 2000-09-22 2000-09-22
PCT/US2001/028406 WO2002024690A2 (en) 2000-09-22 2001-09-12 Efficient process for the preparation of a factor xa inhibitor

Publications (2)

Publication Number Publication Date
NO20031308D0 NO20031308D0 (no) 2003-03-21
NO20031308L true NO20031308L (no) 2003-05-07

Family

ID=22882119

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031308A NO20031308L (no) 2000-09-22 2003-03-21 Effektiv fremgangsmåte for fremstilling av en faktor XA- inhibitor

Country Status (23)

Country Link
US (3) US6667332B2 (cs)
EP (1) EP1366045A2 (cs)
JP (1) JP2004529853A (cs)
KR (1) KR20040043089A (cs)
CN (1) CN1610679A (cs)
AU (1) AU2001292612A1 (cs)
BG (1) BG107813A (cs)
BR (1) BR0114102A (cs)
CA (1) CA2424576A1 (cs)
CZ (1) CZ2003835A3 (cs)
EE (1) EE200300116A (cs)
HR (1) HRP20030316A2 (cs)
HU (1) HUP0500133A2 (cs)
IL (1) IL155043A0 (cs)
IS (1) IS6754A (cs)
MX (1) MXPA03002493A (cs)
NO (1) NO20031308L (cs)
PL (1) PL366027A1 (cs)
RU (1) RU2003111464A (cs)
SK (1) SK4892003A3 (cs)
TW (1) TW593314B (cs)
WO (1) WO2002024690A2 (cs)
ZA (1) ZA200302971B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339099B1 (en) * 1997-06-20 2002-01-15 Dupont Pharmaceuticals Company Guanidine mimics as factor Xa inhibitors
EP1301479A2 (en) * 2000-07-18 2003-04-16 Bone Care International, Inc. STABILIZED 1$g(a)-HYDROXY VITAMIN D
TW200302225A (en) * 2001-12-04 2003-08-01 Bristol Myers Squibb Co Substituted amino methyl factor Xa inhibitors
AU2003270861A1 (en) * 2002-10-02 2004-04-23 Bristol-Myers Squibb Company Novel combination of a factor xa inhibitor and clopidogrel
AU2003277565A1 (en) 2002-11-06 2004-06-07 Matsushita Electric Industrial Co., Ltd. Microactuator provided with diplacement detection function, and deformable mirror provided with this microactuator
US7429581B2 (en) * 2002-12-23 2008-09-30 Sanofi-Aventis Deutschland Gmbh Pyrazole-derivatives as factor Xa inhibitors
US20050059719A1 (en) * 2003-09-16 2005-03-17 Badawy Sherif Ibrahim Farag Solid dosage formulation containing a Factor Xa inhibitor and method
CN106257976B (zh) 2014-03-07 2021-02-02 拜奥克里斯特制药公司 人类血浆激肽释放酶抑制剂
CN119626346B (zh) * 2025-02-14 2025-05-06 四川省肿瘤医院 一种医学基因测序数据的模式识别方法及设备

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020357A (en) * 1996-12-23 2000-02-01 Dupont Pharmaceuticals Company Nitrogen containing heteroaromatics as factor Xa inhibitors
ZA985247B (en) * 1997-06-19 1999-12-17 Du Pont Merck Pharma Guanidine mimics as factor Xa inhibitors.
US6339099B1 (en) * 1997-06-20 2002-01-15 Dupont Pharmaceuticals Company Guanidine mimics as factor Xa inhibitors

Also Published As

Publication number Publication date
WO2002024690A8 (en) 2002-08-08
TW593314B (en) 2004-06-21
EE200300116A (et) 2005-04-15
US20020061917A1 (en) 2002-05-23
CZ2003835A3 (cs) 2003-12-17
KR20040043089A (ko) 2004-05-22
PL366027A1 (en) 2005-01-24
EP1366045A2 (en) 2003-12-03
NO20031308D0 (no) 2003-03-21
MXPA03002493A (es) 2004-09-10
HRP20030316A2 (en) 2005-02-28
BG107813A (bg) 2004-01-30
IL155043A0 (en) 2003-10-31
BR0114102A (pt) 2005-04-19
CN1610679A (zh) 2005-04-27
WO2002024690A3 (en) 2003-09-25
JP2004529853A (ja) 2004-09-30
HUP0500133A2 (hu) 2005-04-28
RU2003111464A (ru) 2004-10-27
US20040198787A1 (en) 2004-10-07
IS6754A (is) 2003-03-21
US6667332B2 (en) 2003-12-23
SK4892003A3 (en) 2004-04-06
AU2001292612A1 (en) 2002-04-02
WO2002024690A2 (en) 2002-03-28
ZA200302971B (en) 2005-05-09
US20030212117A1 (en) 2003-11-13
CA2424576A1 (en) 2002-03-28
US6747158B2 (en) 2004-06-08

Similar Documents

Publication Publication Date Title
NO20021230D0 (no) Inhibitorer for faktor Xa
ATE346050T1 (de) Substituierte oxoazaheterocyclyl faktor xa hemmer
NO20013072L (no) Nitrogenholdige heterocykler som faktor Xa-inhibitorer
IL149292A0 (en) Method for graphically defining a formula
DE60123294D1 (de) Diazepan Derivate als Faktor X Inhibitor
NO996316D0 (no) Faktor Xa-inhibitorer med en noeytral P1-spesifisitetsgruppe
NO20011293L (no) Faktor VIIa-inhibitorer
DE59808842D1 (de) Benzamidinderivate als faktor xa-inhibitoren
FI20000869A0 (fi) Menetelmä kiinnirullaimen toimintavarmuuden parantamiseksi
NO20021414D0 (no) Fremgangsmåte for forbedring av permeabiliteten av en undergrunnspetroleuminneholdende formasjon
DE60113024T2 (de) Vorrichtung zum schutz einer wand
NO20042990L (no) Pyrrolidin-2-oner som faktor XA inhibitorer
DK1395553T3 (da) Pyrrolidinderivater som faktor Xa-inhibitorer
DE60115513D1 (de) Beschichtungsverfahren
NO20031308D0 (no) Effektiv fremgangsmåte for fremstilling av en faktor XA- inhibitor
ATE246707T1 (de) Faktor viia inhibitore
FI20000369L (fi) Menetelmä kefalokuvauksen suorittamiseksi
DE60206376D1 (de) Faktor xa inhibitor
FI113053B (fi) Menetelmä polyaniliinin valmistamiseksi
NO20032366D0 (no) Fremgangsmåte for produksjon av en hydraulisk trubinkomponent
FR2802198B1 (fr) Machine a sections individuelles
NO324220B1 (no) Fremgangsmate for fremstilling av en polymorf
ITVI990085A0 (it) Macchina di ribobinatura a spire accostate
FI991617L (fi) Menetelmä vasteen tuottamiseksi
EP1255617A4 (en) A coating method

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application